1 – 10 of 193
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Effects of levodopa–entacapone–carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson’s disease—interim analysis of the ELEGANCE study
- Contribution to journal › Article
-
Mark
Infusion therapies for Parkinson’s disease : where are we in 2025?
- Contribution to journal › Article
-
Mark
Documented End-of-Life Preferences of People With Parkinson's Disease or Parkinsonism Across Europe
- Contribution to journal › Article
-
Mark
Clinical aspects of impulsive-compulsive behaviors under dopaminergic treatment-A scoping review
- Contribution to journal › Scientific review
-
Mark
Suicidal behaviour and suicide mortality in Parkinson’s disease: a nationwide register-based cohort study
- Contribution to journal › Article
- 2025
-
Mark
Impulse control disorders in Parkinson’s disease : a national Swedish registry study on high-risk treatments and vulnerable patient groups
- Contribution to journal › Article
-
Mark
Balance and gait disorders in de novo Parkinson’s disease : support for early rehabilitation
- Contribution to journal › Article
-
Mark
Drug-Induced Cognitive Impairment
- Contribution to journal › Scientific review
-
Mark
Levodopa–entacapone–carbidopa intestinal gel : Data from the Swedish national registry for Parkinson's disease
- Contribution to journal › Article
-
Mark
Recognition, management, and patient perspectives of impulsive-compulsive disorders in Parkinson's disease
- Contribution to journal › Article
